These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Significance of repeat injection of contrast medium in the genesis of kidney and spinal cord damage resulting from abdominal aortography. KILLEN DA; LANCE EM Ann Surg; 1960 Aug; 152(2):231-9. PubMed ID: 14409067 [No Abstract] [Full Text] [Related]
5. [ON NEW CONTRAST MEDIA FOR INTRAVENOUS INJECTION; CONRAY AND ANGIO-CONRAY]. OHKOSHI M; NAMAKAME Y; FUJIMURA S; KUDO S Rinsho Hoshasen; 1964 Jul; 9():547-57. PubMed ID: 14198875 [No Abstract] [Full Text] [Related]
6. RELATIVE NEPHROTOXICITY OF HYPAQUE AND ANGIO-CONRAY. RHEA WG; KILLEN DA; FOSTER JH Surgery; 1965 Apr; 57():554-8. PubMed ID: 14275783 [No Abstract] [Full Text] [Related]
7. Experimental studies of angio-conray: a new angiographic agent. BERNSTEIN EF; RELLER CR; GRAGE TB Radiology; 1962 Sep; 79():389-94. PubMed ID: 13868264 [No Abstract] [Full Text] [Related]
8. Angio-Conray: a new angiographic contrast agent. KANICK V; FINBY N Radiology; 1963 Mar; 80():438-43. PubMed ID: 13962235 [No Abstract] [Full Text] [Related]
9. [CLINICAL EVALUATION OF TWO NEW CONTRAST MEDIA: CONRAY AND ANGIO-CONRAY; APPLICATION TO THE RAPID-SEQUENCE INTRAVENOUS PYELOGRAPHY AND THE TRANSLUMBAR AORTOGRAPHY]. KUSUNOKI T; ISOBE Y Hinyokika Kiyo; 1964 Sep; 10():635-40. PubMed ID: 14227902 [No Abstract] [Full Text] [Related]
10. Significance of repeat injections of contrast medium in the genesis of spinal cord damage resulting from aortography. KILLEN DA; LANCE EM Surg Forum; 1960; 10():469-71. PubMed ID: 14409068 [No Abstract] [Full Text] [Related]
11. A SEVERE REACTION TO ANGIO-CONRAY. LAMPE WT Radiology; 1964 Mar; 82():456-8. PubMed ID: 14127174 [No Abstract] [Full Text] [Related]
12. SODIUM IOTHALAMATE, ANGIO-CONRAY, IN SELECTIVE ANGIOGRAPHY: FURTHER EVIDENCE OF LOW TOXICITY. MUDD JG; WILLMAN VL Am J Roentgenol Radium Ther Nucl Med; 1963 Dec; 90():1287-9. PubMed ID: 14081438 [No Abstract] [Full Text] [Related]
13. Tolerance of the kidneys to the contrast medium urografin. SMIDDY FG; ANDERSON GK Br J Urol; 1960 Jun; 32():156-9. PubMed ID: 13831805 [No Abstract] [Full Text] [Related]
14. Histological features of glomerula and tubules after the injection of an iodated contrast medium (uroselectan B 75 per cent) through puncture of the left ventricle for renal angiography (Experimental study). SADI A; MITRI MALULI A; SAAD F Urol Int; 1961; 11():193-201. PubMed ID: 13745277 [No Abstract] [Full Text] [Related]
15. Investigation of means to prevent spinal cord and renal damage incident to Urokon aortography. KILLEN DA; LANCE EM Surgery; 1962 Mar; 51():338-46. PubMed ID: 14455924 [No Abstract] [Full Text] [Related]
16. Iothalamate (Conray, Angio-Conray), a new cardiovascular contrast agent of low toxicity, low viscosity and high opacity. STRAUBE KR; DOTTER CT J Cardiovasc Surg (Torino); 1963 Jun; 4():400-2. PubMed ID: 13978785 [No Abstract] [Full Text] [Related]
17. Experimental appraisal of the agents employed as angiocardiographic and aortographic contrast media. II. Nephrotoxicity. KILLEN DA; LANCE EM Surgery; 1960 Feb; 47():260-5. PubMed ID: 14409066 [No Abstract] [Full Text] [Related]
18. Glucose protection of the canine kidney against urokon injury during abdominal aortography. LANCE EM; KILLEN DA Surg Forum; 1960; 11():139-40. PubMed ID: 13758616 [No Abstract] [Full Text] [Related]
20. A report of a case of the injection of a massive dose of urografin into the renal artery. LAUBSCHER WM; RAPER FP Br J Urol; 1960 Jun; 32():160-4. PubMed ID: 14414490 [No Abstract] [Full Text] [Related] [Next] [New Search]